// App-Quantinova.ai

1305-271 : INAPPROPRIATE ORAL ANTICOAGULANT USE IN ATRIAL FIBRILLATION PATIENTS WITH A LOW RISK OF THROMBOEMBOLISM: INSIGHTS FROM THE NCDR PINNACLE PROGRAM

Researchers

Presenter

  • Jonathan Hsu

Principal Investigators

  • Paul Chan

  • Fengming Tang

  • Thomas Dewland

  • Thomas Maddox

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Structural Heart Disease

  • Arrhythmia

  • Venous thrombosis

Biomarkers

  • Acetyl-CoA carboxylase

Drug/Treatment

  • rivaroxaban

  • Pradax

  • Warfarin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved